PHENOTYPIC ANALYSIS OF YELLOW-FEVER VIRUS DERIVED FROM COMPLEMENTARY-DNA

被引:19
作者
MARCHEVSKY, RS
MARIANO, J
FERREIRA, VS
ALMEIDA, E
CERQUEIRA, MJ
CARVALHO, R
PISSURNO, JW
DAROSA, APAT
SIMOES, MC
SANTOS, CND
FERREIRA, II
MUYLAERT, IR
MANN, GF
RICE, CM
GALLER, R
机构
[1] FUNDACAO OSWALDO CRUZ,INST TECNOL IMUNOBIOL,DEPT BIOQUIM & BIOL MOLEC,BR-21045900 RIO JANEIRO,BRAZIL
[2] WASHINGTON UNIV,SCH MED,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110
[3] INST EVANDRO CHAGAS,SECAO ARBOVIRUS,BR-66090000 BELEM,PARA,BRAZIL
关键词
D O I
10.4269/ajtmh.1995.52.75
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A thorough phenotypic characterization of yellow fever (YF) virus generated from cDNA is a necessary prerequisite for mapping virulence/attenuation determinants and exploring the potential of YF attenuated virus 17D as a carrier for heterologous protective epitopes. In this study, YF virus was produced from 17D cDNA clones after lipofectin-mediated RNA transfection of certified primary cultures of chicken embryo fibroblasts (YFiV5.2/SL). This virus was passaged once in embryonated chicken eggs according to current YF vaccine manufacture methodology to produce the experimental virus (YFiv5.2/VL). These viruses were characterized in established monkey neurovirulence safety tests and quantitative clinical and histologic scores were derived for each virus. The experimental vaccine viruses (YFiV5.2/SL and VL) compared favorably with another well-known YF vaccine strain (17DD) used as control virus for the histologic score. Although slightly higher clinical neurovirulence was observed for YFiv5.2 as compared with the 17DD virus, it should not preclude the use of YFiv5.2 for mapping YF virus virulence determinants.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 14 条
[1]   IDENTIFICATION OF MONOCLONAL-ANTIBODIES THAT DISTINGUISH BETWEEN 17D-204 AND OTHER STRAINS OF YELLOW-FEVER VIRUS [J].
BARRETT, ADT ;
MATHEWS, JH ;
MILLER, BR ;
MEDLEN, AR ;
LEDGER, TN ;
ROEHRIG, JT .
JOURNAL OF GENERAL VIROLOGY, 1990, 71 :13-18
[2]   ANTIGENIC RELATIONSHIPS BETWEEN FLAVIVIRUSES AS DETERMINED BY CROSS-NEUTRALIZATION TESTS WITH POLYCLONAL ANTISERA [J].
CALISHER, CH ;
KARABATSOS, N ;
DALRYMPLE, JM ;
SHOPE, RE ;
PORTERFIELD, JS ;
WESTAWAY, EG ;
BRANDT, WE .
JOURNAL OF GENERAL VIROLOGY, 1989, 70 :37-43
[3]   FLAVIVIRUS GENOME ORGANIZATION, EXPRESSION, AND REPLICATION [J].
CHAMBERS, TJ ;
HAHN, CS ;
GALLER, R ;
RICE, CM .
ANNUAL REVIEW OF MICROBIOLOGY, 1990, 44 :649-688
[4]   HIGH GENETIC STABILITY OF THE REGION CODING FOR THE STRUCTURAL PROTEINS OF YELLOW-FEVER VIRUS STRAIN-17D [J].
DESPRES, P ;
CAHOUR, A ;
DUPUY, A ;
DEUBEL, V ;
BOULOY, M ;
DIGOUTTE, JP ;
GIRARD, M .
JOURNAL OF GENERAL VIROLOGY, 1987, 68 :2245-2247
[5]  
FOX JP, 1943, AM J HYG, V38, P52
[6]  
HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2029
[7]   COMPARISON OF THE NUCLEOTIDE AND DEDUCED AMINO-ACID-SEQUENCES OF THE ENVELOPE PROTEIN GENES OF THE WILD-TYPE FRENCH VISCEROTROPIC STRAIN OF YELLOW-FEVER VIRUS AND THE LIVE VACCINE STRAIN, FRENCH NEUROTROPIC VACCINE, DERIVED FROM IT [J].
JENNINGS, AD ;
WHITBY, JE ;
MINOR, PD ;
BARRETT, ADT .
VIROLOGY, 1993, 192 (02) :692-695
[8]   THE MONKEY SAFETY TEST FOR NEUROVIRULENCE OF YELLOW-FEVER VACCINES - THE UTILITY OF QUANTITATIVE CLINICAL-EVALUATION AND HISTOLOGICAL EXAMINATION [J].
LEVENBOOK, IS ;
PELLEU, LJ ;
ELISBERG, BL .
JOURNAL OF BIOLOGICAL STANDARDIZATION, 1987, 15 (04) :305-313
[9]   PATHOPHYSIOLOGIC CORRELATIONS IN A RHESUS-MONKEY MODEL OF YELLOW-FEVER - WITH SPECIAL OBSERVATIONS ON THE ACUTE NECROSIS OF B-CELL AREAS OF LYMPHOID-TISSUES [J].
MONATH, TP ;
BRINKER, KR ;
CHANDLER, FW ;
KEMP, GE ;
CROPP, CB .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1981, 30 (02) :431-443
[10]   HETEROGENEITY IN ENVELOPE PROTEIN-SEQUENCE AND N-LINKED GLYCOSYLATION AMONG YELLOW-FEVER VIRUS-VACCINE STRAINS [J].
POST, PR ;
SANTOS, CND ;
CARVALHO, R ;
CRUZ, ACR ;
RICE, CM ;
GALLER, R .
VIROLOGY, 1992, 188 (01) :160-167